Novelo M et al. |
Cytotoxic constituents from Hyptis verticillata. |
1993 |
J. Nat. Prod. |
pmid:8277312
|
Iwasaki S |
[Inhibitors of tubulin assembly: specially on rhizoxin-maytansine site ligands]. |
1993 |
Tanpakushitsu Kakusan Koso |
pmid:8210422
|
Sawada T et al. |
A fluorescent probe and a photoaffinity labeling reagent to study the binding site of maytansine and rhizoxin on tubulin. |
1993 Jul-Aug |
Bioconjug. Chem. |
pmid:8218485
|
David B et al. |
Rhazinilam mimics the cellular effects of taxol by different mechanisms of action. |
1994 |
Cell Motil. Cytoskeleton |
pmid:7954858
|
Sinha S and Jain S |
Natural products as anticancer agents. |
1994 |
Prog Drug Res |
pmid:7916160
|
Fellous A et al. |
Removal of the projection domain of microtubule-associated protein 2 alters its interaction with tubulin. |
1994 |
J. Protein Chem. |
pmid:7986343
|
Liu C et al. |
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8710920
|
Ladino CA et al. |
Folate-maytansinoids: target-selective drugs of low molecular weight. |
1997 |
Int. J. Cancer |
pmid:9399666
|
Rai SS and Wolff J |
The C terminus of beta-tubulin regulates vinblastine-induced tubulin polymerization. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9539723
|
Jordan A et al. |
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. |
1998 |
Med Res Rev |
pmid:9664292
|
Werbovetz KA et al. |
Purification, characterization, and drug susceptibility of tubulin from Leishmania. |
1999 |
Mol. Biochem. Parasitol. |
pmid:10029309
|
Havens CG et al. |
Cellular effects of leishmanial tubulin inhibitors on L. donovani. |
2000 |
Mol. Biochem. Parasitol. |
pmid:11071278
|
Monneret C and Florent JC |
[Targeting of antitumor drugs with monoclonal antibodies]. |
2000 |
Bull Cancer |
pmid:11125291
|
Smith S |
Technology evaluation: C242-DM1, ImmunoGen Inc. |
2001 |
Curr. Opin. Mol. Ther. |
pmid:11338934
|
Ross S et al. |
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. |
2002 |
Cancer Res. |
pmid:11980648
|
Carroll BJ et al. |
Identification of a set of genes involved in the formation of the substrate for the incorporation of the unusual "glycolate" chain extension unit in ansamitocin biosynthesis. |
2002 |
J. Am. Chem. Soc. |
pmid:11960423
|
Yu TW et al. |
The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12060743
|
Moss SJ et al. |
Identification of asm19 as an acyltransferase attaching the biologically essential ester side chain of ansamitocins using N-desmethyl-4,5-desepoxymaytansinol, not maytansinol, as its substrate. |
2002 |
J. Am. Chem. Soc. |
pmid:12047169
|
Ranson M and Sliwkowski MX |
Perspectives on anti-HER monoclonal antibodies. |
2002 |
Oncology |
pmid:12422051
|
Cruz-Monserrate Z et al. |
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography. |
2003 |
Eur. J. Biochem. |
pmid:12950266
|